Education/CredentialsFellowship: University of Pennsylvania (Gastroenterology)Residency: Mayo Clinic, School of Graduate Medical EducationMD: University of CincinnatiPhD: University of Cincinnati (Molecular and Developmental Biology)BS: University of Western Ontario (Biochemisry) Board Certifications & LicensesAmerican Board of Internal Medicine (Certification Date: 20190814)American Board of Internal Medicine (Gastroenterology) (Certification Date: 20221116) SpecialtiesDigestive DiseasesInternal Medicine Contact Information Medical Sciences Building 7263 Office 513-558-5244 Email zandvaik@ucmail.uc.edu Clinical Interests GastroenterologyInternal MedicineDigestive System Disease Peer Reviewed Publications Scorletti, Eleonora; Creasy, Kate Townsend; Vujkovic, Marijana; Vell, Mara; Zandvakili, Inuk; Rader, Daniel J; Schneider, Kai Markus; Schneider, Carolin V 2022. Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease. The American journal of gastroenterology, 117 6, 927-930Sehgal, Kanika; Zandvakili, Inuk; Tariq, Raseen; Pardi, Darrell S; Khanna, Sahil 2022. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert review of anti-infective therapy, 20 4, 577-583Schneider, Carolin V; Schneider, Kai Markus; Conlon, Donna M; Park, Joseph; Vujkovic, Marijana; Zandvakili, Inuk; Ko, Yi-An; Trautwein, Christian; Center, Regerneron; Carr, Rotonya M; Strnad, Pavel; Thaiss, Christoph A; Rader, Daniel J 2021. A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. Med (New York, N.Y.), 2 7, 851-863.e3Schneider, Carolin V; Zandvakili, Inuk; Thaiss, Christoph A; Schneider, Kai Markus 2021. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP reports : innovation in hepatology, 3 3, 100263Calderon, Gerardo; McRae, Alison; Rievaj, Juraj; Davis, Judith; Zandvakili, Inuk; Linker-Nord, Sara; Burton, Duane; Roberts, Geoffrey; Reimann, Frank; Gedulin, Bronislava; Vella, Adrian; LaRusso, Nicholas F; Camilleri, Michael; Gribble, Fiona M; Acosta, Andres 2020. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine, 55 , 102759Zandvakili, Inuk; Lazaridis, Konstantinos N 2019. Cell-free DNA testing: future applications in gastroenterology and hepatology. Therapeutic advances in gastroenterology, 12 , 1756284819841896Zandvakili, Inuk; Lloyd, James W; Giridhar, Karthik V 2019. Hepatitis, Pancreatitis and Rash in a Patient With Chronic Lymphocytic Leukemia. Gastroenterology, 157 4, e8-e9Zandvakili, Inuk; Conboy, Caitlin B; Ayed, Ayed O; Cathcart-Rake, Elizabeth J; Tefferi, Ayalew 2018. Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. American journal of hematology, 93 5, E123-E125Zandvakili, I; Lin, Y; Morris, J C; Zheng, Y 2017. Rho GTPases: Anti- or pro-neoplastic targets? Oncogene, 36 23, 3213-3222Zandvakili, Inuk; Davis, Ashley Kuenzi; Hu, Guodong; Zheng, Yi 2015. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. PloS one, 10 6, e0127923Akbari, Mohammad Reza; Ghadirian, Parviz; Robidoux, Andre; Foumani, Maryam; Sun, Yulong; Royer, Robert; Zandvakili, Inuk; Lynch, Henry; Narod, Steven A 2009. Germline RAP80 mutations and susceptibility to breast cancer. Breast cancer research and treatment, 113 2, 377-81Young, S R; Pilarski, Robert T; Donenberg, Talia; Shapiro, Charles; Hammond, Lyn S; Miller, Judith; Brooks, Karen A; Cohen, Stephanie; Tenenholz, Beverly; Desai, Damini; Zandvakili, Inuk; Royer, Robert; Li, Song; Narod, Steven A 2009. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC cancer, 9 , 86Akbari, M R; Malekzadeh, R; Nasrollahzadeh, D; Amanian, D; Islami, F; Li, S; Zandvakili, I; Shakeri, R; Sotoudeh, M; Aghcheli, K; Salahi, R; Pourshams, A; Semnani, S; Boffetta, P; Dawsey, S M; Ghadirian, P; Narod, S A 2008. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene, 27 9, 1290-6
Peer Reviewed Publications Scorletti, Eleonora; Creasy, Kate Townsend; Vujkovic, Marijana; Vell, Mara; Zandvakili, Inuk; Rader, Daniel J; Schneider, Kai Markus; Schneider, Carolin V 2022. Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease. The American journal of gastroenterology, 117 6, 927-930Sehgal, Kanika; Zandvakili, Inuk; Tariq, Raseen; Pardi, Darrell S; Khanna, Sahil 2022. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert review of anti-infective therapy, 20 4, 577-583Schneider, Carolin V; Schneider, Kai Markus; Conlon, Donna M; Park, Joseph; Vujkovic, Marijana; Zandvakili, Inuk; Ko, Yi-An; Trautwein, Christian; Center, Regerneron; Carr, Rotonya M; Strnad, Pavel; Thaiss, Christoph A; Rader, Daniel J 2021. A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. Med (New York, N.Y.), 2 7, 851-863.e3Schneider, Carolin V; Zandvakili, Inuk; Thaiss, Christoph A; Schneider, Kai Markus 2021. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP reports : innovation in hepatology, 3 3, 100263Calderon, Gerardo; McRae, Alison; Rievaj, Juraj; Davis, Judith; Zandvakili, Inuk; Linker-Nord, Sara; Burton, Duane; Roberts, Geoffrey; Reimann, Frank; Gedulin, Bronislava; Vella, Adrian; LaRusso, Nicholas F; Camilleri, Michael; Gribble, Fiona M; Acosta, Andres 2020. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine, 55 , 102759Zandvakili, Inuk; Lazaridis, Konstantinos N 2019. Cell-free DNA testing: future applications in gastroenterology and hepatology. Therapeutic advances in gastroenterology, 12 , 1756284819841896Zandvakili, Inuk; Lloyd, James W; Giridhar, Karthik V 2019. Hepatitis, Pancreatitis and Rash in a Patient With Chronic Lymphocytic Leukemia. Gastroenterology, 157 4, e8-e9Zandvakili, Inuk; Conboy, Caitlin B; Ayed, Ayed O; Cathcart-Rake, Elizabeth J; Tefferi, Ayalew 2018. Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. American journal of hematology, 93 5, E123-E125Zandvakili, I; Lin, Y; Morris, J C; Zheng, Y 2017. Rho GTPases: Anti- or pro-neoplastic targets? Oncogene, 36 23, 3213-3222Zandvakili, Inuk; Davis, Ashley Kuenzi; Hu, Guodong; Zheng, Yi 2015. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. PloS one, 10 6, e0127923Akbari, Mohammad Reza; Ghadirian, Parviz; Robidoux, Andre; Foumani, Maryam; Sun, Yulong; Royer, Robert; Zandvakili, Inuk; Lynch, Henry; Narod, Steven A 2009. Germline RAP80 mutations and susceptibility to breast cancer. Breast cancer research and treatment, 113 2, 377-81Young, S R; Pilarski, Robert T; Donenberg, Talia; Shapiro, Charles; Hammond, Lyn S; Miller, Judith; Brooks, Karen A; Cohen, Stephanie; Tenenholz, Beverly; Desai, Damini; Zandvakili, Inuk; Royer, Robert; Li, Song; Narod, Steven A 2009. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC cancer, 9 , 86Akbari, M R; Malekzadeh, R; Nasrollahzadeh, D; Amanian, D; Islami, F; Li, S; Zandvakili, I; Shakeri, R; Sotoudeh, M; Aghcheli, K; Salahi, R; Pourshams, A; Semnani, S; Boffetta, P; Dawsey, S M; Ghadirian, P; Narod, S A 2008. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene, 27 9, 1290-6
Scorletti, Eleonora; Creasy, Kate Townsend; Vujkovic, Marijana; Vell, Mara; Zandvakili, Inuk; Rader, Daniel J; Schneider, Kai Markus; Schneider, Carolin V 2022. Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease. The American journal of gastroenterology, 117 6, 927-930Sehgal, Kanika; Zandvakili, Inuk; Tariq, Raseen; Pardi, Darrell S; Khanna, Sahil 2022. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert review of anti-infective therapy, 20 4, 577-583Schneider, Carolin V; Schneider, Kai Markus; Conlon, Donna M; Park, Joseph; Vujkovic, Marijana; Zandvakili, Inuk; Ko, Yi-An; Trautwein, Christian; Center, Regerneron; Carr, Rotonya M; Strnad, Pavel; Thaiss, Christoph A; Rader, Daniel J 2021. A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. Med (New York, N.Y.), 2 7, 851-863.e3Schneider, Carolin V; Zandvakili, Inuk; Thaiss, Christoph A; Schneider, Kai Markus 2021. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP reports : innovation in hepatology, 3 3, 100263Calderon, Gerardo; McRae, Alison; Rievaj, Juraj; Davis, Judith; Zandvakili, Inuk; Linker-Nord, Sara; Burton, Duane; Roberts, Geoffrey; Reimann, Frank; Gedulin, Bronislava; Vella, Adrian; LaRusso, Nicholas F; Camilleri, Michael; Gribble, Fiona M; Acosta, Andres 2020. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine, 55 , 102759Zandvakili, Inuk; Lazaridis, Konstantinos N 2019. Cell-free DNA testing: future applications in gastroenterology and hepatology. Therapeutic advances in gastroenterology, 12 , 1756284819841896Zandvakili, Inuk; Lloyd, James W; Giridhar, Karthik V 2019. Hepatitis, Pancreatitis and Rash in a Patient With Chronic Lymphocytic Leukemia. Gastroenterology, 157 4, e8-e9Zandvakili, Inuk; Conboy, Caitlin B; Ayed, Ayed O; Cathcart-Rake, Elizabeth J; Tefferi, Ayalew 2018. Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. American journal of hematology, 93 5, E123-E125Zandvakili, I; Lin, Y; Morris, J C; Zheng, Y 2017. Rho GTPases: Anti- or pro-neoplastic targets? Oncogene, 36 23, 3213-3222Zandvakili, Inuk; Davis, Ashley Kuenzi; Hu, Guodong; Zheng, Yi 2015. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. PloS one, 10 6, e0127923Akbari, Mohammad Reza; Ghadirian, Parviz; Robidoux, Andre; Foumani, Maryam; Sun, Yulong; Royer, Robert; Zandvakili, Inuk; Lynch, Henry; Narod, Steven A 2009. Germline RAP80 mutations and susceptibility to breast cancer. Breast cancer research and treatment, 113 2, 377-81Young, S R; Pilarski, Robert T; Donenberg, Talia; Shapiro, Charles; Hammond, Lyn S; Miller, Judith; Brooks, Karen A; Cohen, Stephanie; Tenenholz, Beverly; Desai, Damini; Zandvakili, Inuk; Royer, Robert; Li, Song; Narod, Steven A 2009. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC cancer, 9 , 86Akbari, M R; Malekzadeh, R; Nasrollahzadeh, D; Amanian, D; Islami, F; Li, S; Zandvakili, I; Shakeri, R; Sotoudeh, M; Aghcheli, K; Salahi, R; Pourshams, A; Semnani, S; Boffetta, P; Dawsey, S M; Ghadirian, P; Narod, S A 2008. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene, 27 9, 1290-6